Correlation Between GATA-3, Ki67 and p53 Expressions to Histopathology Grading of Breast Cancer in Makassar, Indonesia by Andi Asadul Islam, Andi Asadul Islam
See	discussions,	stats,	and	author	profiles	for	this	publication	at:	https://www.researchgate.net/publication/299645821
Correlation	Between	GATA-3,	Ki67	and	p53
Expressions	to	Histopathology	Grading	of
Breast	Cancer	in	Makassar,	Indonesia
Article	·	January	2016
DOI:	10.11648/j.crj.20160403.11
CITATIONS
0
READS
62
9	authors,	including:
Some	of	the	authors	of	this	publication	are	also	working	on	these	related	projects:
Infectious	diseases	View	project
TB	Spondilytis	View	project
Andi	Islam
Universitas	Hasanuddin
23	PUBLICATIONS			6	CITATIONS			
SEE	PROFILE
William	Hamdani
Universitas	Hasanuddin
7	PUBLICATIONS			8	CITATIONS			
SEE	PROFILE
Mochammad	Hatta
Universitas	Hasanuddin
249	PUBLICATIONS			2,841	CITATIONS			
SEE	PROFILE
All	content	following	this	page	was	uploaded	by	Mochammad	Hatta	on	05	April	2016.
The	user	has	requested	enhancement	of	the	downloaded	file.
 Cancer Research Journal 
2016; 4(3): 43-47 
http://www.sciencepublishinggroup.com/j/crj 
doi: 10.11648/j.crj.20160403.11 
ISSN: 2330-8192 (Print); ISSN: 2330-8214 (Online)  
 
Correlation Between GATA-3, Ki67 and p53 Expressions to 
Histopathology Grading of Breast Cancer in Makassar, 
Indonesia 
Syarif Ibrahim
1
, Rosdiana Natzir
2
, Andi Asadul Islam
3
, Tjakra Manuaba
4
,  
A. Benyamin Fachruddin
5
, Burhanuddin Bahar
6
, William Hamdani
7
, Husni Cangara
8
,  
Mochammad Hatta
9, * 
1Department of Surgery, Wahidin Sudirohusodo General Hospital, Makassar, Indonesia 
2Department of Biochemistry, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia 
3Department of Surgery, Neuro Surgery Division, Wahidin Sudirohusodo General Hospital/Faculty of Medicine, Hasanuddin University, 
Makassar, Indonesia 
4Department of Surgery, Sanglah General Hospital/Faculty of Medicine, Udayana University, Denpasar, Indonesia 
5Department of Internal Division, Wahidin Sudirohusodo General Hospital/Faculty of medicine, Hasanuddin University, Makassar, Indonesia 
6Department of Epidemiology Faculty of Public Health, Hasanuddin University, Makassar, Indonesia 
7Department of Surgery, Wahidin Sudirohusodo General Hospital, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia 
8Department of Pathology Anatomy, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia 
9Molecular Biology and Immunology Laboratory, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia 
Email address: 
syarifibrahim57@gmail.com (S. Ibrahim), Rosdiananatzir@yahoo.com (R. Natzir), Andiasadul@yahoo.com (A. A. Islam), 
Breastca04@yahoo.com (T. Manuaba), Andifach@yahoo.co.id (A. B. Fachruddin), Ninaisywara14@yahoo.co.id (B. Bahar), 
Williamhamdani_mks@yahoo.co.id (W. Hamdani), husnicangara@yahoo.com (H. Cangara), Hattaram@indosat.net.id (M. Hatta) 
*Corresponding author 
To cite this article: 
Syarif Ibrahim, Rosdiana Natzir, Andi Asadul Islam, Tjakra Manuaba, A. Benyamin Fachruddin, Burhanuddin Bahar, William Hamdani, Husni 
Cangara, Mochammad Hatta. Correlation Between GATA-3, Ki67 and p53 Expressions to Histopathology Grading of Breast Cancer in Makassar, 
Indonesia. Cancer Research Journal. Vol. 4, No. 3, 2016, pp. 43-47. doi: 10.11648/j.crj.20160403.11 
Received: February 2, 2016; Accepted: February 24, 2016; Published: April 1, 2016 
 
Abstract: Background: During the last two decades, research about GATA-3, Ki-67, p53 expressions have been done, but it is 
still a debate on their use in predicting breast cancer patients’ prognosis and survival rate. Expressions of GATA-3 decreased with 
increasing of histopathology grading of breast cancer and increase with decrease of histopathology grading of breast cancer. The 
level expression of Ki-67 has a positive relation with breast cancer histopathology grading. p53 has no correlation with high grade 
differentiation of breast cancer. p53 is a transcription factor which is activated as a part of cellular stress response that can regulate 
genes’ cellular process, including apoptosis and senescence. Aim: To determine correlation between expressions of GATA 3, Ki-67 
and p53 with histopathology grading of breast cancer in Makassar, Indonesia. Methods: Antibody monoclonal GATA 3, Ki-67 and 
p53 on the nucleus cell were detected with immunohistochemistry method. The positive and negative expressions of GATA 3, Ki-
67 and p53 were assessed using scoring system according to the proportion of positive cell and coloring intensities. Results: There 
is no correlation between the higher positive expression ofp53 and higher expression of histopathology grading of breast cancer (P 
= 0.089). While Ki-67 had positive association with higher grade malignancy (P = 0.03). However, there was no association 
between GATA-3 expression and histopathology grading. Conclusion: In our research we found there is no correlation between 
higher expression of p53 and low expression of GATA-3 with higher histopathology grading of breast cancer. High expression of 
Ki-67 have significantly statistic analysis with high expression of histopathology grading of mammary cancer. 
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1. Introduction 
Breast cancer is a malignancy that occurs in the breast 
gland. Breast cancer ranks first of the ten types of cancer in 
women. It was reported incidence of breast cancer in all over 
the world increase twice, this is the highest level during the 
late 30 years. WHO predicted the incidence rate of all cancer 
were 11 millions and every year the amount of breast cancer 
increase to 7 millions. 
In the United States in 2005 reported the incidence of breast 
cancer by two hundred eleven thousands two hundred fourty 
(211,240) new cases (ACS, 2006). In 2007 the incidence of 
breast cancer was reported increase to two hundred fourty 
three thousands (243,000) with sixty two thousands (62,000) 
among them with Carcinoma In Situ (CIS). Breast cancer 
incidence has increased every year. Data from the American 
Cancer Society in 2010, stated that there are two hundred 
seven thousands ninety (207,090) new cases of breast cancer 
in women in the USA with the estimated number of deaths 
about thirty nine thousands eight hundred fourty (39,840) 
cases [1]. This figure makes breast cancer as the second most 
common cause of death in women after lung cancer. 
In Indonesia the incidence of breast cancer reported twenty 
thousands (20,000) new cases/year, around hundred (100) 
cases among one hundred thousands (100,000) women. 50% 
were hospitalized in late stages [2]. 
In Wahidin Sudirohusodo Hospital in Makassar, Indonesia 
the incidence of breast cancer in 2007 were 163 new cases 
and became 189 new cases in 2008. There is increasing cases 
of late stage of mammary cancer and metastatic stage from 
69.9% in the year 2007 became 74.1% in the year of 2008 
(Wahidin Sudirohusodo Hospital Information System).  
Ki-67 expression as detected by immunohistochemistry is 
one of the most variable indicators of the proliferative status 
of cancer cells and is referred to as Ki-67. In 2009 at the St-
Gallen breast cancer conference, Ki-67 was recommended as 
a biomarker for prognosis and sensitivity of cancers to 
endocrine therapy or chemotherapy [3].
  
Expression of transcription factor GATA-3 has been shown to 
be important for normal breast glandular cell development as 
well for maintaining the differentiated state of cells [4]. 
Expression of GATA-3 was significantly increased in breast 
cancer. Decreasing of GATA-3 expressions correlate with 
increasing tumor histological grade and high patient survival [5]. 
Expression of p53 in higher differentiated with high 
proliferation fraction may indicate greater tumor 
aggressiveness and high risk of relapse [6]. p53 is a critical 
tumor suppressor that maintains the genetic stability in 
mammals by having multiple roles in cells cycle arrest, 
apoptosis, senescence and differentiation. Loss of p53 
functions is required for the progression of most cancers. The 
expression of mutant p53 is correlated with the poor prognosis. 
The aim of our study was to investigate the expression of p53, 
Ki-67 and GATA-3 in correlation with histopathology grading 
among 50 nested sampling in pathological anatomy laboratory 
medical faculty in Makassar. 
2. Methods 
A total of 50 cases of breast cancer were studied in 
laboratory of anatomic pathology Wahidin Sudirohusodo 
general hospital Faculty of Medicine, Hasanuddin University 
Makassar, Indonesia The research was performed from 
October2015 to November 2015 in women from 27 to 73 
years old. Fresh tissue from biopsy or tumorectomy was 
received in department of pathological anatomy and put in 
buffered formalin solution. 
2.1. Histopathology Grading Characteristic 
The histopathology grade was determined in sections 
stained with haematoxylin eosin according to the criteria 
established and histological type according to the WHO 
classification (1981). 
2.2. Immunohistochemical Study Determination of 
Expressions of Ki-67 and p53 
Immunohistochemical analyses were determined by the 
expression levels of Ki-67 and p53. Tissues were fixed in 
10% formaldehyde for 24 hours, routinely embedded in 
paraffin and cut into 5-µm sections. Sections were adherent 
to APES coated slides and dried at 60°C for 2 hours [7, 8]. 
Immunohistochemistry was performed according to the 
manufacturer’s instructions, using Streptavidin-Peroxidase 
(SP-9000) kit, anti Ki-67 (ZM0166), p53 (ZM0408), C-erb2 
(ZM0065), all from Zymed laboratories (San Francisco, CA, 
USA) with antigen retrieval performed according to the 
manufacturer’s instruction. The slides were scored by 
counting the number of positive cells regardless of the 
staining intensity versus the total number of cells and 
calculating the percentage of positive cells (positive 
cells/total cells in one field), as previously described, the 
positivity of several fields were averaged and expressed as 
the ratio of positive cells per field to total cells per field: 
<10%, negative, 10% - 20%: weakly positive, 26% - 50%: 
positive, >50%: strong positive. A cut-off point of 25% was 
used to distinguish between the categories of low and high 
proliferative tumors, a value similar to 20% or >20% [9-11].
 
2.3. Immunohistochemistry Staining Procedures of GATA-3 
Tissue in paraffin blocks of size 5-µm was cut and glued on 
the slide poly-L-lysine and then carried. Immunohisto 
chemical staining was using standard methods Avidin-Biotin 
peroxidase Complex (ABC). Slide that has not been colored 
was incubated in 0,1% trypsin solution in citrate buffer pH 6 
for 10 minutes in the microwave with temperature 37°C. After 
that examination followed by standard procedure ABC. 
GATA-3 using GATA-3 monoclonal antibody, at a dilution of 
1: 200 [12]. Results were evaluated by immunohistochemical 
staining using light microscope by 2 pathologists and 
researchers. The expression of GATA-3 is the accumulation of 
GATA-3 in the cell nucleus detected by immunohistochemical 
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methods. Expression of GATA-3 positive when there is a 
brown color in the cell nucleus that is seen with a light 
microscope. This expression is calculated using a scoring 
system based on the proportion of positive cells and the 
intensity of the color. Immunoexpression GATA-3 is expressed 
in a semiquantitative estimation of the scoring system 
percentage. 0: No stained cell nucleus, 1: 1-10% stained, 2: 11-
20%, 3: 21-30%, 4: 31-40%, 5: 41-50%, 6: 51-60%, 7: 61-
70%, 8: 71-80%, 9: 81-90%, 10: 91-100%. Intensity: 1+: weak 
intensity, 2+: moderate intensity, 3+: strong intensity. Last 
score obtained by multiplying the intensity of the presentation 
and the expression of GATA-3 in the cell nucleus to obtain a 
range of scores 0-30. Then was grouped again to Score 0-3 
declared negative, Score 4-30 tested positive [13]. 
2.4. Statistical Analysis 
All the data collection were recorded and then analyzed by 
using software SPSS 17.0 to compare score expressions of 
GATA-3, p53 and Ki-67 to scores of breast cancer 
histopathology grading. Statistical analysis was using chi-
square test. P-value less than 0.05 was considered 
statistically significant. 
3. Results 
3.1. GATA-3, p53, Ki-67 Protein Expression Patterns in 
Breast Tissue 
 
Figure 1. Positive expression of immunohistochemistry of GATA-3 (200 x). 
 
Figure 2. Positive expression of immunohistochemistry of Ki-67 (200 x). 
 
Figure 3. Positive expression of immunohistochemistry of p53 (200 x). 
Characteristics of Samples, The total sample of 50 studies 
examined in laboratory of Pathology Anatomy, Faculty of 
Medicine, Hasanuddin University, Makassar, Indonesia. 
Table 1. Characteristic Sampling of the Research 
Characteristics Total (N) Percentage 
Age 
=40yr 12 24% 
> 40yr 38 76% 
Histopathology 
Grading 
Low Differentiated 10 20% 
High Differentiated 40 60% 
Protein p53 
Negative 23 46% 
Positive 27 54% 
Protein Ki-67 
Negative 17 34% 
Positive 33 66% 
GATA 3 
Negative 15 30% 
Positive 35 70% 
In table 1 the sample was mostly from more than 40 year 
patients with a percentage of 76% or 38 out of 50 samples. 
Low differentiated histopathology grading were 20% (10 
cases) while high differentiated were 80% (40 cases). The 
amount of p53 protein positive expressions were 54% (27 
cases) where the negative p53 expression levels were 46% 
(23 cases). 
Ki-67 positive expressions were 66% (33 cases) and 
negative expressions were 34% (17 cases). GATA-3 positive 
expressions were 70% (35 cases), where negative 
expressions were 30% (15 cases). 
Table 2. Correlation Between The Expression Of Ki67 and Histopathology 
Grading of Breast Cancer. 
  
Histopathology Grading 
Total 
  
Low High 
Ki-67 
Positive 
3 27 30 
6,0% 54,0% 60,0% 
Negative 
7 13 20 
14,0% 26,0% 40,0% 
Total 
10 40 50 
20,0% 80,0% 100,0% 
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Correlation between positive expressions Ki-67 with high 
differentiated histopathology grading were 54% or 27 cases 
out of 50 cases. While in low differentiated positive 
expressions of Ki-67 were found in 3 cases with a percentage 
of 6%. The negative Ki-67 expressions were found in 13 
cases (26%) with high differentiated histopathology grading. 
While negative  
Ki-67 expressions were found in 7 cases (14%) with low 
differentiated histopathology grading. 
Table 3. Correlation Between p53 Expression and Histopathology Grading 
of Breast Cancer. 
  
Histopathology Grading 
Total 
  
Low High 
p53 
Positive 
3 24 27 
6,0% 48,0% 54,0% 
Negative 
7 16 23 
14,0% 32,0% 46,0% 
Total 
10 40 50 
20,0% 80,0% 100,0% 
Correlation of positive p53 with high differentiated 
histopathology grading were 48% (24 cases) while p53 
negative with high differentiated histopathology grading 
were 32% (16 cases). A positive p53 expressions were found 
in 3 cases with low differentiated histopathology grading 
(6%). The percentage of negative p53 expressions with low 
differentiated histopathology grading is 14% (7 cases). 
Table 4. Correlation Between GATA-3 Expression With Histopathology 
Grading Of Breast Cancer. 
  
Histopathology Grading 
Total 
  
Low High 
GATA 3 
Positive 
7 28 35 
14,0% 56,0% 70,0% 
Negative 
3 12 15 
6,0% 24,0% 30,0% 
Total 
10 40 50 
20,0% 80,0% 100,0% 
Positive GATA-3 expressions were seen in high 
differentiated histopathology grading with a percentage of 
56%, 28 among the 50 cases, while GATA-3 negative 
expressions found in high differentiated histopathology 
grading with a percentage of 24% or 12 cases. GATA-3 is 
only visible negative 6% (3 cases) in low differentiated 
histopathology grading. In low differentiated histopathology 
grading, we found 7 cases with positive GATA3 expressions 
(14%). 
3.2. Statistical Analysis 
In the statistical test using chi-square test, turned out that P 
value was less than 0.05 (P = 0.03). This showed that the 
higher the expression of Ki-67 the higher differentiated result 
in histopathology grading. 
In the statistical test using chi-square test we found that P 
was greater than 0.05 (P = 0.089). This shows that the higher 
expression of p53 was not correlated significantly with the 
higher histopathology grading in this research. 
In the statistical test using chi-square test we found that P 
was greater than 0.05 (P = 0.1 is not significant). This 
showed that the low negative expression of GATA-3 was not 
significantly correlated with higher differentiated 
histopathology grading in this research. 
4. Discussion 
The mutation of p53 gene is a common phenomenon in 
numerous human tumors, leading to the accumulation of 
nonfunctioning p53 protein in the cell nucleus, which can be 
detected by Immunohistochemistry. 
In breast cancer, it has been suggested that the over 
expression of p53 protein in the nucleus is an indicator of 
poor prognosis, which must be borne in mind in selecting 
coadjuvant treatment for each patient [14].
 
In our study we found a positive p53 expression in high 
histologic grading is 48.0% among 50 cases and a negative 
p53 expression in 16 cases (32.0%) where in statistical 
analysis there is no correlation between a high expression of 
p53 and higher histologic grading of tumor (P = 0.089). 
Sirvent, Salvado et al. study about IHC analysis of p53 
expression in 153 cases of breast cancer, correlating with 
histological grade, axillary node status, hormone receptors, 
cell proliferation fraction and expression of the c-erB-2 
oncoprotein. Of all the breast cancer tissue analyzed, 43.97% 
were positive p53, over expression of this protein show direct 
statistically significant relationship to histological grade, cell 
proliferation faction and c-erB-2, but had no statistically 
significant relationship with axillary node status. 
Mutation and the over expression of p53 protein are 
directly related to histological grade [14]. 
GATA-3 is a nuclear of GATA-3 transcriptions regulatory 
family and is important in directing cell fate. Development 
and or differentiation in a member of cell types including 
luminal epithelial cells of mammary gland. GATA-3 is a 
member of the GATA-3 transcription regulatory family and is 
important in directing cell fate, development, and or 
differentiation in a number of cell types including luminal 
epithelial cells of the mammary gland. Although we and 
others have shown that GATA-3 levels were generally higher 
in malignant cells compared with morphologically normal 
epithelium, within malignant tissue, relatively lower levels of 
GATA-3 portended a poorer outcome compared with 
relatively higher expression. Consistent with the role of 
GATA-3 in the development and differentiation of normal 
mammary epithelium, we further observed that lower levels 
of GATA-3 were generally associated with a higher-grade, 
less differentiated malignancy [4]. 
In this study, we used a IHC to reassess associations of 
GATA-3 expression with Histopathologic grading of 50 
samples of breast cancer in Makassar. We found that positive 
expression of GATA-3 had amount of 28 samples (28%) 
among high histopathologic grading of breast cancer. Even 
though the higher expression positive GATA-3 seen in high 
histopathologic grading but there is no statistically 
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significant correlation between them. Negative (low) 
expression GATA-3 only had 12 samples among high level of 
histologic grading (20%) of the result. 
Mehra et al. found low GATA-3 expression was associated 
with higher histologic grade (P < 0.001), positive nodes (P = 
0.002), larger tumor size (P = 0.03), negative estrogen 
receptor and progesterone receptor (P < 0.001 for both) [5]. 
Ki-67 protein (also known as MKI67) is a cellular marker 
for proliferation. This nuclear protein is expressed in 
proliferating cells during G1 through M phases of the cell 
cycle, but is not detected in resting cells. The Ki-67 
expression as detected by immunohistochemistry is one of 
the most reliable indicators of the proliferative status of 
cancer cells and is referred to as Ki-67 henceforward. In 
2009, at the St-Gallen breast cancer conference, Ki-67 was 
recommended as a biomarker for prognosis and sensitivity of 
cancer cells to endocrine therapy or chemotherapy. In 2011, 
Ki-67 was regarded as one of the factors influencing 
molecular subtypes. Ki-67 expression is closely associated 
with the growth and invasion of breast cancer: Ki-67 positive 
breast cancers are more active in growth, more aggressive in 
invasion, and more metastatic [3, 7]. 
In conclusion, we found there is no correlation between 
higher expression of p53 and low expression of GATA-3 with 
higher histopathology grading of breast cancer. High 
expression of Ki-67 have significantly statistic analysis with 
high expression of histopathology grading of mammary 
cancer. 
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